Skip to main content
. 2022 Jan 13;29:101206. doi: 10.1016/j.bbrep.2022.101206

Fig. 1.

Fig. 1

The alteration of DND1 gene in human cancers as identified by 32 TCGA PanCancer Atlas studies. RCCC, Kidney Renal Clear Cell Carcinoma; ChCa, Cholangiocarcinoma; UCS, Uterine Carcinosarcoma; UCEC, Uterine Corpus Endometrial Carcinoma; PanC, Pancreatic Adenocarcinoma; UM, Uveal Melanoma; MSTO, Mesothelioma; SA, Stomach Adenocarcinoma; ACC, Adrenocortical Carcinoma; OSC, Ovarian Serous Cystadenocarcinoma; ProA, Prostate Adenocarcinoma; CA, Colorectal Adenocarcinoma; LSCC, Lung Squamous Cell Carcinoma; LA, Lung Adenocarcinoma; TGCT, Testicular Germ Cell Tumors; EA, Esophageal Adenocarcinoma; BIC, Breast Invasive Carcinoma; SCM, Skin Cutaneous Melanoma; HNSCC, Head and Neck Squamous Cell Carcinoma; LHCC, Liver Hepatocellular Carcinoma; BUC, Bladder Urothelial Carcinoma; TC, Thyroid Carcinoma; BLGG, Brain Lower Grade Glioma; GBM, Glioblastoma Multiforme; AML, Acute Myeloid Leukemia; CSCC, Cervical Squamous Cell Carcinoma; DLBCL, Diffuse Large B-Cell Lymphoma; KC, Kidney Chromophobe; RPCC, Kidney Renal Papillary Cell Carcinoma; PP, Pheochromocytoma and Paraganglioma.